Table 2 The association of the clinical features and the expression of IMP3 with the prognosis of 73 patients with ovarian clear cell carcinoma

Age

0.097

0.071

≥60y

0.084

0.073

17

5

2

19

<60y

29

22

15

36

Tumor size

0.222

0.415

≥15 cm

0.337

0.285

8

8

5

11

<15 cm

38

19

12

44

Lateral

0.786

0.038

Unilateral

/

/

37

21

40

17

Bilateral

9

6

15

0

CA125

0.115

0.375

Above normal

0.201

0.935

29

18

10

34

Normal

8

1

3

5

Ascites

0.347

0.521

Present

0.055

0.271

19

14

9

7

Absent

24

11

24

27

Endometriosis

0.352

/

/

/

Present

0.534

0.424

9

8

Absent

36

19

Necrosis

0.260

0.296

Present

0.377

0.499

16

13

5

24

Absent

30

14

12

31

Papillary component

0.188

0.631

Present

0.123

0.180

37

18

12

42

Absent

9

9

5

13

Mitotic figures (/10 HPF)

0.488

0.660

<10

0.712

0.947

40

24

12

44

≥10

6

2

1

6

Stage

0.074

0.038

I

<0.001

<0.001

19

17

12

23

II–IV

27

10

5

32

DFS

44

18

0.175

OS

44

18

0.012